REG - Fevertree Drinks PLC - Transaction in Own Shares

Fevertree DrinksAnnouncement

Tue 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260414:nRSN2465Aa&default-theme=true

RNS Number : 2465A  Fevertree Drinks PLC  14 April 2026

14(th) April 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 7(th)
April to 10(th) April 2026.

 Date           Venue  Volume-weighted average price (p)  Aggregated volume               Lowest price per share (p)  Highest price per share (p)
 07 April 2026  XLON   769.0583                                      25,209               748.0000                    779.0000
 07 April 2026  AIMX   776.0000                                      20,000               776.0000                    776.0000
 08 April 2026  XLON   801.5459                                        1,701              779.5000                    804.0000
 09 April 2026  XLON   805.0083                                      40,209               802.0000                    814.5000
 10 April 2026  XLON   817.0306                                      41,011               806.0000                    824.0000

 

The Company intends to cancel the purchased shares.

 

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/2465A_1-2026-4-13.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2465A_1-2026-4-13.pdf)

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSXXLFFQZLBBBZ



            Copyright 2019 Regulatory News Service, all rights reserved